Trials / Terminated
TerminatedNCT05014698
IDEntification of New Predisposition Genes in Differentiated THYroid Cancer
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Nantes University Hospital · Academic / Other
- Sex
- All
- Age
- 8 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research is to find new predisposition genes for differentiated thyroid cancer (DTC).
Detailed description
The purpose of this research is to find new predisposition genes for differentiated thyroid cancer (DTC). Therefore, in the absence of a BAP1 and DICER1 abnormality, we offer to sequence your whole genome (WGS) or partial genome (genotyping) for a previously unknown genetic abnormality. Furthermore, the discovery of new genes would be a major medical advance that could contribute to the identification of new therapeutic targets. This research will be conducted at the University Hospital of Nantes and the Hospital of Vendée and 95 people should participate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | WGS | Whole Genome sequencing |
Timeline
- Start date
- 2022-02-23
- Primary completion
- 2026-01-13
- Completion
- 2026-01-13
- First posted
- 2021-08-20
- Last updated
- 2026-01-28
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05014698. Inclusion in this directory is not an endorsement.